BenzingaAugust 7, 2026 at 3:30 PM NY2 Months Ago
UBS Maintains Buy on Steris, Lowers Price Target to $270
UBS analyst Patrick Wood maintains Steris (NYSE:STE) with a Buy and lowers the price target from $275 to $270.
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site: Benzinga
